Summary | |
---|---|
Symbol | CMTM6 |
Name | CKLF-like MARVEL transmembrane domain containing 6 |
Aliases | FLJ20396; CKLFSF6; chemokine-like factor super family 6; chemokine-like factor superfamily 6; PRO2219; chemo ...... |
Chromosomal Location | 3p22.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | Cell membrane Multi-pass membrane protein Early endosome membrane Multi-pass membrane protein Recycling endosome membrane Multi-pass membrane protein Note=Co-localizes with PD-L1/CD274 in the plasma membrane and in recycling endosomes. |
Domain |
PF01284 Membrane-associating domain |
Function |
Master regulator of recycling and plasma membrane expression of PD-L1/CD274, an immune inhibitory ligand critical for immune tolerance to self and antitumor immunity. Associates with both constitutive and IFNG-induced PD-L1/CD274 at recycling endosomes, where it protects PD-L1/CD274 from being targeted for lysosomal degradation, likely by preventing its STUB1-mediated ubiquitination. May stabilize PD-L1/CD274 expression on antigen presenting cells and potentiates inhibitory signaling by PDCD1/CD279, its receptor on T-cells, ultimately triggering T-cell anergy. |
Biological Process | - |
Molecular Function |
GO:0005125 cytokine activity |
Cellular Component | - |
KEGG | - |
Reactome |
R-HSA-168256: Immune System R-HSA-168249: Innate Immune System R-HSA-6798695: Neutrophil degranulation |
Summary | |
---|---|
Symbol | CMTM6 |
Name | CKLF-like MARVEL transmembrane domain containing 6 |
Aliases | FLJ20396; CKLFSF6; chemokine-like factor super family 6; chemokine-like factor superfamily 6; PRO2219; chemo ...... |
Chromosomal Location | 3p22.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between CMTM6 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
Literatures describing the relation between CMTM6 and anti-tumor immunity in human cancer.
|
Summary | |
---|---|
Symbol | CMTM6 |
Name | CKLF-like MARVEL transmembrane domain containing 6 |
Aliases | FLJ20396; CKLFSF6; chemokine-like factor super family 6; chemokine-like factor superfamily 6; PRO2219; chemo ...... |
Chromosomal Location | 3p22.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of CMTM6 in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | CMTM6 |
Name | CKLF-like MARVEL transmembrane domain containing 6 |
Aliases | FLJ20396; CKLFSF6; chemokine-like factor super family 6; chemokine-like factor superfamily 6; PRO2219; chemo ...... |
Chromosomal Location | 3p22.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of CMTM6 in various data sets.
|
Points in the above scatter plot represent the mutation difference of CMTM6 in various data sets.
|
Summary | |
---|---|
Symbol | CMTM6 |
Name | CKLF-like MARVEL transmembrane domain containing 6 |
Aliases | FLJ20396; CKLFSF6; chemokine-like factor super family 6; chemokine-like factor superfamily 6; PRO2219; chemo ...... |
Chromosomal Location | 3p22.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of CMTM6. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | CMTM6 |
Name | CKLF-like MARVEL transmembrane domain containing 6 |
Aliases | FLJ20396; CKLFSF6; chemokine-like factor super family 6; chemokine-like factor superfamily 6; PRO2219; chemo ...... |
Chromosomal Location | 3p22.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of CMTM6. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by CMTM6. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | CMTM6 |
Name | CKLF-like MARVEL transmembrane domain containing 6 |
Aliases | FLJ20396; CKLFSF6; chemokine-like factor super family 6; chemokine-like factor superfamily 6; PRO2219; chemo ...... |
Chromosomal Location | 3p22.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of CMTM6. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | CMTM6 |
Name | CKLF-like MARVEL transmembrane domain containing 6 |
Aliases | FLJ20396; CKLFSF6; chemokine-like factor super family 6; chemokine-like factor superfamily 6; PRO2219; chemo ...... |
Chromosomal Location | 3p22.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of CMTM6 expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | CMTM6 |
Name | CKLF-like MARVEL transmembrane domain containing 6 |
Aliases | FLJ20396; CKLFSF6; chemokine-like factor super family 6; chemokine-like factor superfamily 6; PRO2219; chemo ...... |
Chromosomal Location | 3p22.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between CMTM6 and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |
Summary | |
---|---|
Symbol | CMTM6 |
Name | CKLF-like MARVEL transmembrane domain containing 6 |
Aliases | FLJ20396; CKLFSF6; chemokine-like factor super family 6; chemokine-like factor superfamily 6; PRO2219; chemo ...... |
Chromosomal Location | 3p22.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Drugs targeting CMTM6 collected from DrugBank database. |
There is no record. |